Patents by Inventor Dieter Scheller

Dieter Scheller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treating Parkinson's Disease
    Publication number: 20160367560
    Abstract: The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
    Type: Application
    Filed: June 17, 2016
    Publication date: December 22, 2016
    Inventors: Anne Michel, Patrick Downey, Florian Montel, Dieter Scheller, Bernard Christophe
  • Methods for treating Parkinson's disease
    Patent number: 9387212
    Abstract: The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: July 12, 2016
    Assignee: UCB Biopharma SPRL
    Inventors: Anne Michel, Patrick Downey, Florian Montel, Dieter Scheller, Bernard Christophe
  • Method of treating diseases that respond to therapy by dopamine or dopamine agonists
    Patent number: 9108900
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: August 18, 2015
    Assignee: UCB PHARMA GMBH
    Inventors: Dieter Scheller, Klaus Hansen
  • Methods for Treating Parkinson's Disease
    Publication number: 20150157638
    Abstract: The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
    Type: Application
    Filed: April 19, 2013
    Publication date: June 11, 2015
    Inventors: Anne Michel, Patrick Downey, Florian Montel, Dieter Scheller, Bernard Christophe
  • Use of rotigotine for the treatment of depression
    Patent number: 8754119
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: June 17, 2014
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • METHOD OF TREATING DISEASES THAT RESPOND TO THERAPY BY DOPAMINE OR DOPAMINE AGONISTS
    Publication number: 20140051768
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Application
    Filed: October 25, 2013
    Publication date: February 20, 2014
    Applicant: UCB Pharma GmbH
    Inventors: Dieter Scheller, Klaus Hansen
  • (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
    Patent number: 8609641
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Grant
    Filed: December 13, 2004
    Date of Patent: December 17, 2013
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Klaus Hansen
  • Use of substituted 2-aminotetralins for preventive treatment of parkinson's disease
    Patent number: 8283376
    Abstract: The invention relates to the use of substituted 2-aminotetralins of general formula (I) as a medicament for the preventive treatment of Parkinson's disease.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: October 9, 2012
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Frank Dressen
  • Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
    Patent number: 8008351
    Abstract: The present invention is directed to the use of a class of peptide compounds for the prophylaxis and treatment of chronic headache, particularly migraines.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: August 30, 2011
    Assignee: UCB Pharma GmbH
    Inventors: Dieter Scheller, Thomas Stöhr
  • METHOD FOR TREATING PAIN USING A SUBSTITUTED 2-AMINOTETRALIN COMPOUND
    Publication number: 20110104281
    Abstract: A method for treating pain, particularly non-inflammatory musculoskeletal pain such as myofascial pain or back pain, in a subject comprises administering to the subject a substituted 2-aminotetralin compound as defined herein, illustratively rotigotine.
    Type: Application
    Filed: January 5, 2011
    Publication date: May 5, 2011
    Applicant: UCB PHARMA GMBH
    Inventors: Bettina Beyreuther, Dieter Scheller, Joachim Freitag, Joseph Bianchine
  • Use of rotigotine for treating and preventing Parkinson's plus syndrome
    Patent number: 7872041
    Abstract: The invention relates to the use of rotigotine, its salts and prodrugs, as a medicament for preventing and/or treating Parkinson's plus syndrome.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: January 18, 2011
    Assignee: UCB Pharma GmbH
    Inventor: Dieter Scheller
  • Use of Peptide Compounds For the Prophylaxis and Treatment of Chronic Headache
    Publication number: 20080287545
    Abstract: The present invention is directed to the use of a class of peptide compounds for the prophylaxis and treatment of chronic headache, particularly migraines.
    Type: Application
    Filed: April 15, 2005
    Publication date: November 20, 2008
    Applicant: SCHWARZ PHARMA AG
    Inventors: Dieter Scheller, Thomas Stohr
  • Use Of Substituted 2-Aminotetralins For Preventive Treatment Of Parkinson's Disease
    Publication number: 20080146622
    Abstract: The invention relates to the use of substituted 2-aminotetralins of general formula (I) as a medicament for the preventive treatment of Parkinson's disease.
    Type: Application
    Filed: December 23, 2004
    Publication date: June 19, 2008
    Applicant: SRZ Properties, Inc.
    Inventor: Dieter Scheller
  • METHOD FOR TREATING PAIN USING A SUBSTITUTED 2-AMINOTETRALIN COMPOUND
    Publication number: 20080008748
    Abstract: A method for treating pain, particularly non-inflammatory musculoskeletal pain such as fibromyalgia, myofascial pain or back pain, in a subject comprises administering to the subject a substituted 2-aminotetralin compound as defined herein, illustratively rotigotine.
    Type: Application
    Filed: June 19, 2007
    Publication date: January 10, 2008
    Inventors: Bettina Beyreuther, Dieter Scheller, Joachim Freitag, Josephe Bianchine
  • (S)-2-N-Propylamino-5-Hydroxytetralin As A D3-Agonist
    Publication number: 20070197480
    Abstract: The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.
    Type: Application
    Filed: December 13, 2004
    Publication date: August 23, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Klaus Hansen
  • Use of rotigotine for treating and preventing parkinson's plus syndrome
    Publication number: 20070191470
    Abstract: The invention relates to the use of rotigotine, its salts and prodrugs, as a medicament for preventing and/or treating Parkinson's plus syndrome
    Type: Application
    Filed: March 22, 2005
    Publication date: August 16, 2007
    Inventor: Dieter Scheller
  • Use of rotigotine for the treatment of depression
    Publication number: 20070093546
    Abstract: The present invention relates to the use of rotigotine [(?)-5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthol] and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent for treating depression.
    Type: Application
    Filed: July 22, 2004
    Publication date: April 26, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Substituted 2-aminotetralin for the treatment of depression
    Publication number: 20070072917
    Abstract: The invention relates to the use of a compound of general formula (I) and the pharmaceutically acceptable salts, racemates or pure enantiomers thereof for the production of a medicament used to treat depression. The substituents are defined as in the description.
    Type: Application
    Filed: July 22, 2004
    Publication date: March 29, 2007
    Applicant: SRZ Properties, Inc.
    Inventors: Dieter Scheller, Alexander Breidenbach, Norma Selve
  • Use of rotigotine for treatment or prevention of dopaminergic neuron loss
    Publication number: 20050197385
    Abstract: The present patent application relates to the use of Rotigotine or its salts and prodrugs for preparation of a drug for treatment or prophylaxis of dopaminergic cell loss due to diseases that are connected with an increased dopaminergic cell loss. In particular, the patent application is related to the use of Rotigotine as a drug for preventive treatment of Morbus Parkinson.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 8, 2005
    Inventors: Dieter Scheller, Frank Dressen